Kyungbo Pharmaceutical Obtains Patent for High-Purity Palonosetron Intermediate Manufacturing Method

[Asia Economy Reporter Minwoo Lee] Kyungbo Pharmaceutical announced on the 10th that it has obtained a patent for the "High-Purity Palonosetron Intermediate Manufacturing Method." The company stated, "This patent relates to a high-purity manufacturing method of palonosetron intermediate compounds," and explained, "It provides a method to manufacture high-purity and stereoselective palonosetron intermediates by reacting racemic intermediates under conditions of inorganic bases and mixed solvents."

This content was produced with the assistance of AI translation services.